Status | Study |
NOT_YET_RECRUITING |
Study Name: A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Condition: Date: 2023-05-24 Interventions: Weekly telephone calls during the first month, biweekly during the next 5 months, and then monthly for the last 7 months (13 months total).Each |
NOT_YET_RECRUITING |
Study Name: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Condition: Endometrial Hyperplasia Date: 2023-04-12 Interventions: This medication is self-administered as a subcutaneous injection in the abdomen, thigh, or upper arm; injection site should be rotated when using the |
Recruiting |
Study Name: Irisin Hormone Levels in Endometrial Hyperplasia Condition: Endometrial Hyperplasia Date: 2016-09-13 |
Completed |
Study Name: Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia Condition: Apoptotic Signal Pathways in Endometrial Hyperplasia Date: 2016-08-16 Interventions: Drug: 17β estradiol hemihydrate |
Recruiting |
Study Name: Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study Condition: Endometrial Hyperplasia Date: 2015-04-04 |
Active, not recruiting |
Study Name: The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy Condition: Grade 1 Endometrial Endometrioid Adenocarcinoma Grade 2 Endometrial Endometrioid Adenocarcin Date: 2014-12-22 Interventions: Drug: Depot medroxyprogesterone acetate |
Completed |
Study Name: OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer Condition: Endometrial Cancer Atypical Hyperplasia Date: 2013-10-09 Interventions: Procedure: hysteroscopy/curettage in case of suspicious aspect will be done a rapid section Other Name: |
Withdrawn |
Study Name: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer Condition: Atypical Endometrial Hyperplasia Endometrial Adenocarcinoma Date: 2013-09-11 Interventions: Drug: megestrol acetate Given |
Recruiting |
Study Name: Improving the Treatment for Women With Early Stage Cancer of the Uterus Condition: Complex Endometrial Hyperplasia With Atypia Grade 1 Endometrial Date: 2012-09-12 Interventions: Drug: Levonorgestrel Intrauter |
Active, not recruiting |
Study Name: Metformin for the Treatment of Endometrial Hyperplasia Condition: Endometrial Hyperplasia Endometrial Hyper Date: 2012-07-26 Interventions: Drug: Metformin 850 mg of metformin taken once daily by mouth for 4 weeks (weeks 1-4) and then twice dai |